ISSN 2146-8389
 
2018, Vol: 8, Issue: 1
8/1Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to uploaded

Author Statement

Original Research (Original Article) 


Development of a neuroprotective antioxidant by a mix-and-match strategy

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew.

Cited by (1)

Abstract
The compound 4-{[(4-hydroxyphenyl)amino]methyl}-2,6-di-tert-butylphenol (TRS1) was developed using a "mix-and-match" drug design approach for antioxidant-based neuroprotection and therapy. The commonly-used antipyretic drug, paracetamol, which is also found to act as a mild anti-inflammatory, was further modified by attaching a radical scavenger moiety to design a bifunctional bioactive molecule. Using a cell-free 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical reduction assay, and a 2',7'-dichlorofluorescein (DCFH) oxidation assay in cultured N2a mouse neuroblastoma and SH-SY5Y human neuroblastoma cells exposed to oxidative insult (serum deprivation), the radical scavenging ability of TRS1 was found to be comparable with other well-studied antioxidants such as Trolox. The maintenance of antioxidant action of this compound in cells suggests this avenue and other multi-targeted drug discovery paradigms may provide potential therapeutic strategies for targeting complicated neurodegenerative conditions.

Key words: Mix-and-match; Multi-target drug discovery; Neuroprotection; Radical scavenger; Prostaglandin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Vijaya B. Kenche
Articles by Carolin Tumpach
Articles by Kevin J. Barnham
Articles by Steven J. Collins
Articles by Cathryn L. Haigh
Articles by Simon C. Drew
on Google
on Google Scholar
Article Statistics
 Viewed: 2786
Downloaded: 643
Cited: 1

REFERENCES
1.Halliwell B, Gutteridge, JMC. Free Radicals in Biology and Medicine. 4th edition, Oxford University Press, Oxford, 1999.


2.Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120:483-95.

http://dx.doi.org/10.1016/j.cell.2005.02.001

[Pubmed]   


3.Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21:383-421.

http://dx.doi.org/10.1016/S0197-4580(00)00124-X

[Pubmed]   

4.Davies KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 1995; 61:1-31.

[Pubmed]   


5.Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408:239-47.

http://dx.doi.org/10.1038/35041687

[Pubmed]   


6.Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot 2003; 91:179-94.

http://dx.doi.org/10.1093/aob/mcf118

[Pubmed]   


7.Knight JA. Free radicals: their history and current status in aging and disease. Ann Clin Lab Sci 1998; 28:331-46.

[Pubmed]   


8.Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ, for the Members of the Alzheimer's Disease Cooperative Study. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997; 336:1216-22.

http://dx.doi.org/10.1056/NEJM199704243361704

[Pubmed]   


9.Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am J Clin Nutr 2000; 71:630-6S.

[Pubmed]   


10.Shoulson I. DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism. Ann Neurol 1998; 44:S160-6.

[Pubmed]   


11.McGeer PL, McGeer EG. Inflammation of the brain in Alzheimer's disease: implications for therapy. J Leukoc Biol 1999; 65:409-15.

[Pubmed]   


12.Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012; 188:21-8.

http://dx.doi.org/10.4049/jimmunol.1101029

[Pubmed]    [PMC Free Fulltext]   


13.Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ. Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Curr Med Chem 2008; 15:1863-9.

http://dx.doi.org/10.2174/092986708785132915

[Pubmed]    [PMC Free Fulltext]   


14.Almer G, Teismann P, Stevic Z, Halaschek–Wiener J, Deecke L, Kostic V, Przedborski S. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 2002; 58:1277-9.

http://dx.doi.org/10.1212/WNL.58.8.1277

[Pubmed]   


15.Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol 2013; 9:25-34.

http://dx.doi.org/10.1038/nrneurol.2012.236

[Pubmed]   


16.McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 1996; 47:425-32.

http://dx.doi.org/10.1212/WNL.47.2.425

[Pubmed]   


17.McGeer PL. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease. Drugs Aging 2000; 17:1-11.

http://dx.doi.org/10.2165/00002512-200017010-00001

[Pubmed]   


18.Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brand J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995; 45:51-55.

http://dx.doi.org/10.1212/WNL.45.1.51

[Pubmed]   


19.Bishop TS, Sham P. Analysis of Multifactorial Diseases. Academic Press, New York, pp 1-320, 2000.

[Pubmed]   


20.Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen P; EU/US/CTAD Task Force Members. Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force. Alzheimers Dement 2013; 9:438-44.

http://dx.doi.org/10.1016/j.jalz.2013.03.007

[Pubmed]   


21.Bolognesi ML, Simoni E, Rosini M, Minarini A, Tumiatti V, Melchiorre C. Multitarget-directed ligands: innovative chemical probes and therapeutic tools against Alzheimer's disease. Curr Top Med Chem 2011; 11:2797-806.

http://dx.doi.org/10.2174/156802611798184373

[Pubmed]   


22.Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem 2005; 48:6523-43.

http://dx.doi.org/10.1021/jm058225d

[Pubmed]   


23.Bolognesi ML, Bartolini M, Tarozzi A, Morroni F, Lizzi F, Milelli A, Minarini A, Rosini M, Hrelia P, Andrisano V, Melchiorre C. Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity. Bioorg Med Chem Lett 2011; 21:2655-8.

http://dx.doi.org/10.1016/j.bmcl.2010.12.093

[Pubmed]   


24.Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005; 26:178-82.

http://dx.doi.org/10.1016/j.tips.2005.02.007

[Pubmed]   


25.Chao X, He X, Yang Y, Zhou X, Jin M, Liu S, Cheng Z, Liu P, Wang Y, Yu J, Tan Y, Huang Y, Qin J, Rapposelli S, Pi R. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease. Bioorg Med Chem Lett 2012; 22:6498-502.

http://dx.doi.org/10.1016/j.bmcl.2012.08.036

[Pubmed]   


26.Cherezova EN, Zhukova RS, Gorshunova NR, Cherezov SV, Mukmeneva NA. Reaction of Dimethyl(3,5-di-tert-butyl-4-hydroxybenzyl)amine with substituted arylamines. Russ J Gen Chem 1997; 67:932-5.


27.Rondinini S, Mussini PR, Mussini T, Vertova A. pH measurements in non-aqueous and mixed solvents: predicting pH(PS) of potassium hydrogen phthalate for alcohol-water mixtures. Pure Appl Chem 1998; 70:1419-22.

http://dx.doi.org/10.1351/pac199870071419


28.Friaa O, Brault D. Kinetics of the reaction between the antioxidant Trolox and the free radical DPPH• in semi-aqueous solution. Org Biomol Chem 2006; 4:2417-23.

http://dx.doi.org/10.1039/b602147f

[Pubmed]   


29.Huang D, Ou B, Prior RL. The Chemistry behind Antioxidant Capacity Assays. J Agric Food Chem 2005, 53:1841-56.

http://dx.doi.org/10.1021/jf030723c

[Pubmed]   


30.Alisi MA, Brufani M, Cazzolla N, Ceccacci F, Dragone P, Felici M, Furlotti G, Garofalo B, La Bella A, Lanzalunga O, Leonelli F, Bettolo RM, Maugeri C, Migneco LM, Russo V. DPPH radical scavenging activity of paracetamol analogues. Tetrahedron 2012, 68:10180-7.

http://dx.doi.org/10.1016/j.tet.2012.09.098


31.Bondet V, Brand-Williams W, Berset C. Kinetics and mechanisms of antioxidant activity using the DPPH• free radical method. LWT Food Sci Technol 1997; 30:609-15.

http://dx.doi.org/10.1006/fstl.1997.0240


32.Fischer V, West PR, Harman LS, Mason RP. Free-radical metabolites of acetaminophen and a dimethylated derivative. Environ Health Perspect 1985; 64:127-37.

http://dx.doi.org/10.1289/ehp.8564127

[Pubmed]    [PMC Free Fulltext]   


33.Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004; 3:205-14.

http://dx.doi.org/10.1038/nrd1330

[Pubmed]   


34.Haigh CL, Drew SC, Boland MP, Masters CL, Barnham KJ, Lawson VA, Collins SJ. Dominant roles of the polybasic proline motif and copper in PrP23-89 mediated stress protection response. J Cell Sci 2009; 122:1518-28.

http://dx.doi.org/10.1242/jcs.043604

[Pubmed]   


35.Martin BD, Schoenhard JA, Sugden KD. Hypervalent chromium mimics reactive oxygen species as measured by the oxidant-sensitive dyes 2',7'-dichlorofluorescin and dihydrorhodamine. Chem Res Toxicol 1998; 11:1402-10.

http://dx.doi.org/10.1021/tx9801559

[Pubmed]   


36.Bonini MG, Rota C, Tomasi A, Mason RP. The oxidation of 2',7'-dichlorofluorescin to reactive oxygen species: a self-fulfilling prophesy? Free Radic Biol Med 2006; 40:968-75.

http://dx.doi.org/10.1016/j.freeradbiomed.2005.10.042

[Pubmed]   


37.LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2',7'-dichiorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5:227-31.

http://dx.doi.org/10.1021/tx00026a012

[Pubmed]   


38.Tocopherol. Available via http://www.chemspider.com/Chemical-Structure.14265.html (Accessed 24 November 2013).


39.Kakarla SK, Fannin JC, Keshavarzian S, Katta A, Paturi S, Nalabotu SK, Wu M, Rice KM, Manzoor K, Walker EM Jr, Blough ER. Chronic acetaminophen attenuates age-associated increases in cardiac ROS and apoptosis in the Fischer Brown Norway rat. Bas Res Cardiol 2010; 105:535-44.

http://dx.doi.org/10.1007/s00395-010-0094-3

[Pubmed]   


40.Rice KM, Meduru S, Kakarla SK, Katta A, Mupparaju SP, Kidd B, Goebel LJ, Blough ER. Chronic paracetamol treatment influences indices of reactive oxygen species accumulation in the aging Fischer 344 X Brown Norway rat aorta. Ann Clin Lab Sci 2012; 42:152-61.

[Pubmed]   


41.Paracetamol. Available via http://www.chemspider.com/Chemical-Structure.1906.html (Accessed 24 November 2013).


42.4-{[(4-Fluorophenyl)amino]methyl}-2,6-bis(2-methyl-2-propanyl)phenol. Available via http://www.chemspider.com/Chemical-Structure.27617599.html (Accessed 24 November 2013).


43.Clissold SP. Paracetamol and phenacetin. Drugs 1986; 32:46-59.

http://dx.doi.org/10.2165/00003495-198600324-00005

[Pubmed]   


44.Greco A, Ajmone-Cat MA, Nicolini A, Sciulli MG, Minghetti L. Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase. J Neurosci Res 2003; 71:844-52.

http://dx.doi.org/10.1002/jnr.10543

[Pubmed]   


45.Botting R, Ayoub SS. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostag Leukotr Ess 2005; 72:85-7.

http://dx.doi.org/10.1016/j.plefa.2004.10.005

[Pubmed]   


46.Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006; 79:9-19.

http://dx.doi.org/10.1016/j.clpt.2005.09.009

[Pubmed]   


47.Ayoub SS, Colville-Nash PR, Willoughby DA, Botting RM. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol 2006; 538:57-65.

http://dx.doi.org/10.1016/j.ejphar.2006.03.061

[Pubmed]   


48.Brunelle M, Sartin EA, Wolfe LG, Sirois J, Dore M. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines. Vet Pathol 2006; 43:656-66.

http://dx.doi.org/10.1354/vp.43-5-656

[Pubmed]   


49.Kang SS, Li T, Xu D, Reinach PS, Lu L. Inhibitory effect of PGE2 on EGF-induced MAP kinase activity and rabbit corneal epithelial proliferation. Invest Ophthalmol Vis Sci 2000; 41:2164-9.

[Pubmed]   


This Article Cited By the following articles

Stable Radical Content and Anti-Radical Activity of Roasted Arabica Coffee: From In-Tact Bean to Coffee Brew
PLOS ONE 2015; 10(4): e0122834.

1
 
How to Cite this Article
Pubmed Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew. Development of a neuroprotective antioxidant by a mix-and-match strategy. Oxid Antioxid Med Sci. 2013; 2(4): 255-264. doi:10.5455/oams.011113.or.055

Web Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew. Development of a neuroprotective antioxidant by a mix-and-match strategy. http://www.ejmoams.com/?mno=41704 [Access: February 17, 2019]. doi:10.5455/oams.011113.or.055

AMA (American Medical Association) Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew. Development of a neuroprotective antioxidant by a mix-and-match strategy. Oxid Antioxid Med Sci. 2013; 2(4): 255-264. doi:10.5455/oams.011113.or.055


Vancouver/ICMJE Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew. Development of a neuroprotective antioxidant by a mix-and-match strategy. Oxid Antioxid Med Sci. (2013), [cited February 17, 2019]; 2(4): 255-264. doi:10.5455/oams.011113.or.055


Harvard Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew (2013) Development of a neuroprotective antioxidant by a mix-and-match strategy. Oxid Antioxid Med Sci, 2 (4), 255-264. doi:10.5455/oams.011113.or.055


Turabian Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew. 2013. Development of a neuroprotective antioxidant by a mix-and-match strategy. Oxidants and Antioxidants in Medical Science, 2 (4), 255-264. doi:10.5455/oams.011113.or.055


Chicago Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew. "Development of a neuroprotective antioxidant by a mix-and-match strategy." Oxidants and Antioxidants in Medical Science 2 (2013), 255-264. doi:10.5455/oams.011113.or.055


MLA (The Modern Language Association) Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew. "Development of a neuroprotective antioxidant by a mix-and-match strategy." Oxidants and Antioxidants in Medical Science 2.4 (2013), 255-264. Print. doi:10.5455/oams.011113.or.055


APA (American Psychological Association) Style

Vijaya B. Kenche, Carolin Tumpach, Kevin J. Barnham, Steven J. Collins, Cathryn L. Haigh, Simon C. Drew (2013) Development of a neuroprotective antioxidant by a mix-and-match strategy. Oxidants and Antioxidants in Medical Science, 2 (4), 255-264. doi:10.5455/oams.011113.or.055




Most Viewed Articles
  • Low intensity radiofrequency radiation: a new oxidant for living cells
    Igor Yakymenko, Evgeniy Sidorik, Diane Henshel, Sergiy Kyrylenko
    Oxid Antioxid Med Sci. 2014; 3(1): 1-3
    » Abstract & References » doi: 10.5455/oams.240314.ed.002

  • Oxidants and antioxidants: friends or foes?
    Sukru Oter, Si Jin, Luca Cucullo, H.J. Damien Dorman
    Oxid Antioxid Med Sci. 2012; 1(1): 1-4
    » Abstract & References » doi: 10.5455/oams.080612.ed.001

  • Effects of free radicals and antioxidants on exercise performance
    Sikiru Lamina, Charles I. Ezema, Anele I. Theresa, Ezugwu U. Anthonia
    Oxid Antioxid Med Sci. 2013; 2(2): 83-91
    » Abstract & References » doi: 10.5455/oams.010413.rv.005

  • Effects of silymarin, N-acetylcysteine and selenium in the treatment of papulopustular acne
    Haidar Hamid Al-Anbari, Ahmed Salih Sahib, Ahmed R. Abu Raghif
    Oxid Antioxid Med Sci. 2012; 1(3): 201-207
    » Abstract & References » doi: 10.5455/oams.290912.or.019

  • Anticancer and free radical scavenging potency of Catharanthus roseus, Dendrophthoe petandra, Piper betle and Curcuma mangga extracts in breast cancer cell lines
    Wahyu Widowati, Tjandrawati Mozef, Chandra Risdian, Yellianty Yellianty
    Oxid Antioxid Med Sci. 2013; 2(2): 137-142
    » Abstract & References » doi: 10.5455/oams.100413.or.038

  • Antimicrobial and antioxidant properties of marine actinomycetes Streptomyces sp VITSTK7
    Mohankumar Thenmozhi, Krishnan Kannabiran
    Oxid Antioxid Med Sci. 2012; 1(1): 51-57
    » Abstract & References » doi: 10.5455/oams.270412.or.005

  • Is it oxidative or free radical stress and why does it matter?
    Boguslaw Lipinski
    Oxid Antioxid Med Sci. 2012; 1(1): 5-9
    » Abstract & References » doi: 10.5455/oams.130312.rv.001

  • Chemical properties of Monodora myristica and its protective potentials against free radicals in vitro
    Ochuko L. Erukainure, Oluwatoyin V. Oke, Folashade O. Owolabi, Funmi O. Kayode, Emmanuel E. Umanhonlen, Muhammad Aliyu
    Oxid Antioxid Med Sci. 2012; 1(2): 127-132
    » Abstract & References » doi: 10.5455/oams.080712.or.009

  • Cytotoxic and proapoptotic activities of gallic acid to human oral cancer HSC-2 cells
    Alyssa G. Schuck, Jeffrey H. Weisburg, Hannah Esan, Esther F. Robin, Ayelet R. Bersson, Jordana R. Weitschner, Tova Lahasky, Harriet L. Zuckerbraun, Harvey Babich
    Oxid Antioxid Med Sci. 2013; 2(4): 265-274
    » Abstract & References » doi: 10.5455/oams.220713.or.051

  • Heparin or EDTA; anticoagulant of choice in free radical estimation?
    Kuldeep Mohanty, Swetasmita Mishra, Jhumur Pani, Tarannum Hasan, Abhishek Purohit, Subhadra Sharma, Rima Dada
    Oxid Antioxid Med Sci. 2012; 1(1): 21-24
    » Abstract & References » doi: 10.5455/oams.130512.br.001

    •
    Most Downloaded
  • Low intensity radiofrequency radiation: a new oxidant for living cells
    Igor Yakymenko, Evgeniy Sidorik, Diane Henshel, Sergiy Kyrylenko
    Oxid Antioxid Med Sci. 2014; 3(1): 1-3
    » Abstract & References » doi: 10.5455/oams.240314.ed.002

  • The antioxidant capacity and immunomodulatory activity of stingless bee honeys proceeding from Costa Rica
    Gabriel Zamora, Kees Beukelman, Bert van den Berg, Maria Laura Arias, Eduardo Umana, Ingrid Aguilar, Linda Quarles van Ufford, Edwin van den Worm, Natalia Fallas, Rebeca Solorzano
    Oxid Antioxid Med Sci. 2015; 4(1): 49-55
    » Abstract & References » doi: 10.5455/oams.180415.or.084

  • Oxidants and antioxidants: friends or foes?
    Sukru Oter, Si Jin, Luca Cucullo, H.J. Damien Dorman
    Oxid Antioxid Med Sci. 2012; 1(1): 1-4
    » Abstract & References » doi: 10.5455/oams.080612.ed.001

  • Is it oxidative or free radical stress and why does it matter?
    Boguslaw Lipinski
    Oxid Antioxid Med Sci. 2012; 1(1): 5-9
    » Abstract & References » doi: 10.5455/oams.130312.rv.001

  • Antimicrobial and antioxidant properties of marine actinomycetes Streptomyces sp VITSTK7
    Mohankumar Thenmozhi, Krishnan Kannabiran
    Oxid Antioxid Med Sci. 2012; 1(1): 51-57
    » Abstract & References » doi: 10.5455/oams.270412.or.005

  • Anticancer and free radical scavenging potency of Catharanthus roseus, Dendrophthoe petandra, Piper betle and Curcuma mangga extracts in breast cancer cell lines
    Wahyu Widowati, Tjandrawati Mozef, Chandra Risdian, Yellianty Yellianty
    Oxid Antioxid Med Sci. 2013; 2(2): 137-142
    » Abstract & References » doi: 10.5455/oams.100413.or.038

  • Effects of free radicals and antioxidants on exercise performance
    Sikiru Lamina, Charles I. Ezema, Anele I. Theresa, Ezugwu U. Anthonia
    Oxid Antioxid Med Sci. 2013; 2(2): 83-91
    » Abstract & References » doi: 10.5455/oams.010413.rv.005

  • Airway antioxidant capacity and pH in chronic obstructive pulmonary disease
    Wei Lee, Hsien Loo, Paul S. Thomas
    Oxid Antioxid Med Sci. 2012; 1(3): 153-160
    » Abstract & References » doi: 10.5455/oams.300812.or.016

  • Protective properties of complex of quercetin, selenium, catechins and curcumin against DNA damage
    Jana Kadrabova, Marica Krajcovicova-Kudlackova, Alexander Madaric, Martina Valachovicova, Csilla Mislanova, Maria Korenovska
    Oxid Antioxid Med Sci. 2012; 1(3): 179-184
    » Abstract & References » doi: 10.5455/oams.180912.or.018

  • Heparin or EDTA; anticoagulant of choice in free radical estimation?
    Kuldeep Mohanty, Swetasmita Mishra, Jhumur Pani, Tarannum Hasan, Abhishek Purohit, Subhadra Sharma, Rima Dada
    Oxid Antioxid Med Sci. 2012; 1(1): 21-24
    » Abstract & References » doi: 10.5455/oams.130512.br.001

    •
    Most Cited Articles
  • Chemical properties of Monodora myristica and its protective potentials against free radicals in vitro
    Ochuko L. Erukainure, Oluwatoyin V. Oke, Folashade O. Owolabi, Funmi O. Kayode, Emmanuel E. Umanhonlen, Muhammad Aliyu
    Oxid Antioxid Med Sci. 2012; 1(2): 127-132
    » Abstract & References » doi: 10.5455/oams.080712.or.009
    Cited : 14 times [Click to see citing articles]

  • Role of free radicals and antioxidants in gynecological cancers: current status and future prospects
    Lokanatha Valluru, Subramanyam Dasari, Rajendra Wudayagiri
    Oxid Antioxid Med Sci. 2014; 3(1): 15-26
    » Abstract & References » doi: 10.5455/oams.201113.rv.011
    Cited : 12 times [Click to see citing articles]

  • Anticancer and free radical scavenging potency of Catharanthus roseus, Dendrophthoe petandra, Piper betle and Curcuma mangga extracts in breast cancer cell lines
    Wahyu Widowati, Tjandrawati Mozef, Chandra Risdian, Yellianty Yellianty
    Oxid Antioxid Med Sci. 2013; 2(2): 137-142
    » Abstract & References » doi: 10.5455/oams.100413.or.038
    Cited : 12 times [Click to see citing articles]

  • Silymarin and naringenin protects nicotine induced oxidative stress in young rats
    Anshu Jain, Nidhi Dwivedi, Rakesh Bhargava, Swaran J.S. Flora
    Oxid Antioxid Med Sci. 2012; 1(1): 41-49
    » Abstract & References » doi: 10.5455/oams.130412.or.004
    Cited : 9 times [Click to see citing articles]

  • Phytochemical and in vitro antioxidant properties of the methanolic extract of fruits of Blighia sapida, Vitellaria paradoxa and Vitex doniana
    Rabiat U. Hamzah, Evans C. Egwim, Adamu Y. Kabiru, Mary B. Muazu
    Oxid Antioxid Med Sci. 2013; 2(3): 217-223
    » Abstract & References » doi: 10.5455/oams.090513.or.043
    Cited : 9 times [Click to see citing articles]

  • Palm vitamin E reduces oxidative stress, and physical and morphological alterations of erythrocyte membranes in streptozotocin-induced diabetic rats
    Fatmah Ali Matough, Siti Balkis Budin, Zariyantey Abdul Hamid, Santhana Raj Louis, Nasar Alwahaibi, Jamaludin Mohamed
    Oxid Antioxid Med Sci. 2012; 1(1): 59-68
    » Abstract & References » doi: 10.5455/oams.300412.or.006
    Cited : 8 times [Click to see citing articles]

  • Peroxidative index as novel marker of hydrogen peroxide involvement in lipid peroxidation from coal dust exposure
    Nia Kania, Bambang Setiawan, Edi Widjajanto, Nurdiana Nurdiana, M. Aris Widodo, H.M.S. Chandra Kusuma
    Oxid Antioxid Med Sci. 2012; 1(3): 209-215
    » Abstract & References » doi: 10.5455/oams.031012.or.020
    Cited : 8 times [Click to see citing articles]

  • Cytotoxic and proapoptotic activities of gallic acid to human oral cancer HSC-2 cells
    Alyssa G. Schuck, Jeffrey H. Weisburg, Hannah Esan, Esther F. Robin, Ayelet R. Bersson, Jordana R. Weitschner, Tova Lahasky, Harriet L. Zuckerbraun, Harvey Babich
    Oxid Antioxid Med Sci. 2013; 2(4): 265-274
    » Abstract & References » doi: 10.5455/oams.220713.or.051
    Cited : 7 times [Click to see citing articles]

  • Barley phenolic compounds impedes oxidative stress in lead acetate intoxicated rabbits
    Kadry Mohamed Sadek
    Oxid Antioxid Med Sci. 2012; 1(2): 141-146
    » Abstract & References » doi: 10.5455/oams.290612.or.008
    Cited : 7 times [Click to see citing articles]

  • Heparin or EDTA; anticoagulant of choice in free radical estimation?
    Kuldeep Mohanty, Swetasmita Mishra, Jhumur Pani, Tarannum Hasan, Abhishek Purohit, Subhadra Sharma, Rima Dada
    Oxid Antioxid Med Sci. 2012; 1(1): 21-24
    » Abstract & References » doi: 10.5455/oams.130512.br.001
    Cited : 6 times [Click to see citing articles]

    •
    This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
    The articles in Oxidants and Antioxidants in Medical Science are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
    Copyright © 2019 Oxidants and Antioxidants in Medical Science All Rights Reserved. Subject to change without notice from or liability to Oxidants and Antioxidants in Medical Science.
    For best results, please use Internet Explorer or Google Chrome

    Contact Information


    Your comments are very important to us

    We welcome your ideas, suggestions, comments, or questions. To reach Editorial Board please use one of the methods provided below.
     
    Call us at (302) 355 0333. Our office hours are Monday - Friday, 8 AM to 5 PM EST.
     
    Or e-mail us at info@ejmanager.com
     
    We will respond within 48 to 72 hours.
     
    Change of address or personal information? Please visit your account at www.ejmanager.com to update your information.
    POLICIES & JOURNAL LINKS
    Author Login
    Reviewer Login
    About Publisher
    Advertising Policy
    Author's Rights and Obligations
    Conflict of Interest Policy
    Editorial Policies
    Peer Review Policy
    Editorial & Peer Review Process
    Publication Ethics and Publication Malpractice Statement
    Plagiarism Policy
    Privacy Policy
    Protection of Research Participants (Statement On Human And Animal Rights)
    Publishing Ethics
    Corrections, Retractions & Expressions of Concern
    Self-Archiving Policies
    Statement of Informed Consent
    Terms of Use